Report cover image

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 27, 2023
Length 111 Pages
SKU # LPI17669841

Description

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Systemic Aspergillosis and Systemic Candidiasis Treatment Industry Forecast” looks at past sales and reviews total world Systemic Aspergillosis and Systemic Candidiasis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Aspergillosis and Systemic Candidiasis Treatment sales for 2023 through 2029. With Systemic Aspergillosis and Systemic Candidiasis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Aspergillosis and Systemic Candidiasis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Systemic Aspergillosis and Systemic Candidiasis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Aspergillosis and Systemic Candidiasis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Aspergillosis and Systemic Candidiasis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Aspergillosis and Systemic Candidiasis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Aspergillosis and Systemic Candidiasis Treatment.

The global Systemic Aspergillosis and Systemic Candidiasis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Systemic Aspergillosis and Systemic Candidiasis Treatment players cover Basilea Pharmaceutica, Astellas Pharma, Ferrer International, Pacgen Life Science, NovaDigm Therapeutics, Cidara Therapeutics, Amplyx Pharmaceuticals, Pfizer and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Aspergillosis and Systemic Candidiasis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Others

Segmentation by application
Chronic Pulmonary Aspergillosis (CPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Basilea Pharmaceutica
Astellas Pharma
Ferrer International
Pacgen Life Science
NovaDigm Therapeutics
Cidara Therapeutics
Amplyx Pharmaceuticals
Pfizer
Novartis
Sanofi
Merck
Bayer
GlaxoSmithKline
Abbott
Cipla

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

111 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size 2018-2029
2.1.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Type
2.2.1 Voriconazole
2.2.2 Liposomal Amphotericin B
2.2.3 Systemic Oral Azoles
2.2.4 Topical Antifungal Agents
2.2.5 Others
2.3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type
2.3.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Type (2018-2023)
2.4 Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Application
2.4.1 Chronic Pulmonary Aspergillosis (CPA)
2.4.2 Allergic Bronchopulmonary Aspergillosis (ABPA)
2.4.3 Gastrointestinal Candidiasis
2.4.4 Genitourinary Tract Candidiasis
2.4.5 Others
2.5 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application
2.5.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Application (2018-2023)
3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Player
3.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Players
3.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Players (2018-2023)
3.1.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Systemic Aspergillosis and Systemic Candidiasis Treatment by Regions
4.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Regions (2018-2023)
4.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
4.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
4.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2018-2023)
5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2018-2023)
6.2 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
6.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment by Country (2018-2023)
7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment by Region (2018-2023)
8.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
10.1.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
10.1.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
10.1.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
10.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Country (2024-2029)
10.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.2.2 Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.2.3 Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.2.4 Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Region (2024-2029)
10.3.1 China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3.3 Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3.4 Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3.5 India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.3.6 Australia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Country (2024-2029)
10.4.1 Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.4.2 France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.4.3 UK Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.4.4 Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.4.5 Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.5.2 South Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.5.3 Israel Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.5.4 Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.5.5 GCC Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
10.6 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Type (2024-2029)
10.7 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Basilea Pharmaceutica
11.1.1 Basilea Pharmaceutica Company Information
11.1.2 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.1.3 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Basilea Pharmaceutica Main Business Overview
11.1.5 Basilea Pharmaceutica Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.2.3 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 Ferrer International
11.3.1 Ferrer International Company Information
11.3.2 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.3.3 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ferrer International Main Business Overview
11.3.5 Ferrer International Latest Developments
11.4 Pacgen Life Science
11.4.1 Pacgen Life Science Company Information
11.4.2 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.4.3 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pacgen Life Science Main Business Overview
11.4.5 Pacgen Life Science Latest Developments
11.5 NovaDigm Therapeutics
11.5.1 NovaDigm Therapeutics Company Information
11.5.2 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.5.3 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 NovaDigm Therapeutics Main Business Overview
11.5.5 NovaDigm Therapeutics Latest Developments
11.6 Cidara Therapeutics
11.6.1 Cidara Therapeutics Company Information
11.6.2 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.6.3 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Cidara Therapeutics Main Business Overview
11.6.5 Cidara Therapeutics Latest Developments
11.7 Amplyx Pharmaceuticals
11.7.1 Amplyx Pharmaceuticals Company Information
11.7.2 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.7.3 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Amplyx Pharmaceuticals Main Business Overview
11.7.5 Amplyx Pharmaceuticals Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.8.3 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.9.3 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.10.3 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.11.3 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Bayer
11.12.1 Bayer Company Information
11.12.2 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.12.3 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Bayer Main Business Overview
11.12.5 Bayer Latest Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Information
11.13.2 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.13.3 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 GlaxoSmithKline Main Business Overview
11.13.5 GlaxoSmithKline Latest Developments
11.14 Abbott
11.14.1 Abbott Company Information
11.14.2 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.14.3 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Abbott Main Business Overview
11.14.5 Abbott Latest Developments
11.15 Cipla
11.15.1 Cipla Company Information
11.15.2 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
11.15.3 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cipla Main Business Overview
11.15.5 Cipla Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us